News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,399 Results
Type
Article (39811)
Company Profile (254)
Press Release (660334)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (204386)
Career Advice (2012)
Deals (35448)
Drug Delivery (95)
Drug Development (81139)
Employer Resources (172)
FDA (16198)
Job Trends (14880)
News (345541)
Policy (32565)
Tag
Academia (2555)
Accelerated approval (5)
Adcomms (21)
Allergies (86)
Alliances (49516)
ALS (94)
Alzheimer's disease (1382)
Antibody-drug conjugate (ADC) (136)
Approvals (16192)
Artificial intelligence (262)
Autoimmune disease (22)
Automation (16)
Bankruptcy (360)
Best Places to Work (11645)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (182)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (290)
Cancer (2313)
Cardiovascular disease (179)
Career advice (1679)
Career pathing (30)
CAR-T (154)
Cell therapy (433)
Cervical cancer (20)
Clinical research (66131)
Collaboration (858)
Company closure (2)
Compensation (557)
Complete response letters (19)
COVID-19 (2596)
CRISPR (41)
C-suite (249)
Cystic fibrosis (101)
Data (2298)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (275)
Diagnostics (6381)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (102)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (87005)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (112758)
Executive appointments (737)
FDA (17560)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (768)
Gene editing (109)
Generative AI (19)
Gene therapy (311)
GLP-1 (716)
Government (4428)
Grass and pollen (4)
Guidances (150)
Healthcare (18834)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (122)
Indications (29)
Infectious disease (2740)
Inflammatory bowel disease (145)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (97)
Interviews (313)
IPO (16533)
IRA (40)
Job creations (3642)
Job search strategy (1424)
Kidney cancer (10)
Labor market (43)
Layoffs (476)
Leadership (17)
Legal (7912)
Liver cancer (76)
Lung cancer (324)
Lymphoma (157)
Machine learning (9)
Management (58)
Manufacturing (322)
MASH (73)
Medical device (13384)
Medtech (13389)
Mergers & acquisitions (19482)
Metabolic disorders (702)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (92)
Neuropsychiatric disorders (27)
Neuroscience (1930)
NextGen: Class of 2025 (6523)
Non-profit (4481)
Now hiring (40)
Obesity (371)
Opinion (204)
Ovarian cancer (81)
Pain (92)
Pancreatic cancer (88)
Parkinson's disease (150)
Partnered (21)
Patents (241)
Patient recruitment (115)
Peanut (46)
People (57410)
Pharmaceutical (63)
Pharmacy benefit managers (19)
Phase I (20612)
Phase II (29133)
Phase III (21682)
Pipeline (1344)
Policy (147)
Postmarket research (2564)
Preclinical (8768)
Press Release (64)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (384)
Real estate (5920)
Recruiting (65)
Regulatory (22345)
Reports (47)
Research institute (2321)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (132)
Series B (88)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3586)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (48)
The Weekly (30)
Vaccines (697)
Venture capitalists (42)
Weight loss (236)
Women's health (36)
Worklife (16)
Date
Today (182)
Last 7 days (931)
Last 30 days (3082)
Last 365 days (32488)
2025 (11685)
2024 (35254)
2023 (40104)
2022 (51230)
2021 (55762)
2020 (54123)
2019 (46565)
2018 (35041)
2017 (32144)
2016 (31522)
2015 (37590)
2014 (31361)
2013 (26382)
2012 (28585)
2011 (29284)
2010 (27353)
Location
Africa (718)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (37950)
Australia (6213)
California (6375)
Canada (2062)
China (533)
Colorado (272)
Connecticut (278)
Delaware (157)
Europe (81512)
Florida (946)
Georgia (212)
Idaho (57)
Illinois (545)
India (25)
Indiana (318)
Iowa (11)
Japan (171)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (922)
Massachusetts (4730)
Michigan (223)
Minnesota (403)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (63)
New Jersey (1782)
New Mexico (28)
New York (1794)
North Carolina (988)
North Dakota (8)
Northern California (2804)
Ohio (208)
Oklahoma (14)
Oregon (34)
Pennsylvania (1430)
Puerto Rico (13)
Rhode Island (33)
South America (1097)
South Carolina (25)
South Dakota (1)
Southern California (2399)
Tennessee (105)
Texas (946)
United States (23891)
Utah (188)
Virginia (151)
Washington D.C. (64)
Washington State (562)
West Virginia (3)
Wisconsin (56)
700,399 Results for "tentarix biotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Tentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEO
Tentarix Biotherapeutics today announced the appointment of Andrew Kidd, MD, as chief executive officer.
April 23, 2024
·
1 min read
Business
AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology and Immunology
AbbVie Inc. (NYSE: ABBV) and Tentarix Biotherapeutics today announced a multi-year collaboration focused on the discovery and development of conditionally-active, multi-specific biologic candidates in oncology and immunology.
February 22, 2024
·
4 min read
Biotech Beach
Tentarix Biotherapeutics Completes Series B Financing Bringing Total Equity and Upfront Deal Consideration to $132 Million
Tentarix Biotherapeutics, a biotechnology company focused on leveraging its proprietary Tentacles™ platform to discover and develop multi-functional, conditional protein therapeutics, today announced it has raised $35 million in a Series B financing led by Amplitude Ventures with participation from Gilead Sciences, Inc., and founding investors Versant Ventures and Samsara BioCapital.
September 6, 2023
·
3 min read
BioForest
Gilead and Tentarix to Discover and Develop Novel Therapies to Address Unmet Medical Needs Across Cancer and Inflammation
Gilead Sciences, Inc. and Tentarix Biotherapeutics announced that the companies established three multi-year collaborations leveraging Tentarix’s proprietary Tentacles™ platform to discover and develop multi-functional, conditional protein therapeutics for oncology and inflammatory diseases.
August 15, 2023
·
5 min read
Antibody-drug conjugate (ADC)
Roche Ups ADC Bet With $1B in Biobucks for Oxford BioTherapeutics
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for undisclosed cancer targets.
March 19, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 12, 2025
·
6 min read
Press Releases
Atara Biotherapeutics Provides Regulatory Updates on EBVALLO™ (tabelecleucel)
May 5, 2025
·
6 min read
Business
Tentarix Biotherapeutics Announces the Strengthening of its Leadership and Advisory Teams
Tentarix Biotherapeutics LP, a biotechnology company developing first-in-class targeted, conditional antibody-based multifunctional biotherapies, today announced the formation of a Scientific Advisory Board (SAB) and appointments to its Board of Directors and leadership team.
May 20, 2022
·
7 min read
Press Releases
Adolore BioTherapeutics to Present at Festival of Biologics USA 2025
April 24, 2025
·
3 min read
Press Releases
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 7, 2025
February 9, 2025
·
1 min read
1 of 70,040
Next
